IVIG is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases. In addition, there has been a substantial increase in IVIG prescriptions for the treatment of off-label indications, such as, specific antibody deficiency, Guillain-Barre syndrome, Inflammatory Myopathies and others. However, factors such as the high cost of IVIG treatment, side effects associated with use of IVIG, stringent government regulations and a lengthy product approval process would hamper its market growth. Despite several challenges such as inadequate supply of immunoglobulins, stringent regulatory policies and the high cost associated with IVIG treatments, the global IVIG market would witness notable growth during the forecast period.
Global IVIG market is segmented based on its types, application and geography. The application segment includes Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukaemia (CLL), Myasthenia Gravis, Multifocal motor neuropathy, Idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barre syndrome, and others. Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP) holds a dominant share in the market due to a large patient population and the unavailability of effective alternatives for IVIG treatment. Geographically, the report covers five key regions, North America, Europe, Asia Pacific, and LAMEA. Presently, North America occupies a majority of the market followed by the Asia Pacific region. High adoption of IVIG therapies and a large pool of patient population in the North American region is a prime factor responsible for the growth of the North America IVIG market. However, in the Asia-pacific region, growing awareness for immunodeficiency disease & neurological disorders along with the increasing preference towards IVIG therapies, largely drives the market. The companies profiled in this report include Baxter international Inc., CSL Limited, Grifols S.A, Octapharma Ag, Kedrion Pharma, LFB group, Biotest AG, china Biologics products Ltd, Bayer Healthcare, and others.
KEY MARKET SEGMENT:
Global IVIG market is segmented based on the application, types and geography
MARKET BY APPLICATION
MARKET BY TYPE
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
Summary Takeda Pharmaceutical Company Limited (Takeda) is a research-based global pharmaceutical company. It focuses on the research & development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and markets photographic chemicals, inorganic chemicals, vitamin bulks, test reagents and clinical diagnostics. Takeda ...
July 2014 | $250 | View Details >>
The United States CT-PET Scanners Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the CT-PET Scanners industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of ...
March 2017 | $3700 | View Details >>
The Global Equipments CA Tumor Markers Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Equipments CA Tumor Markers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Equipments CA Tumor Markers market ...
November 2015 | $2800 | View Details >>
Notes: Sales, means the sales volume of Dental laboratory mixer Revenue, means the sales value of Dental laboratory mixer This report studies sales (consumption) of Dental laboratory mixer in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and ...
November 2016 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research